Teresa Ezponda
Navarre Institute of Health Research(ES)Clinica Universidad de Navarra(ES)Centro de Investigación Biomédica en Red de Cáncer(ES)Universidad de Navarra(ES)Chartered Institute of Management Accountants(GB)
Publications by Year
Research Areas
Acute Myeloid Leukemia Research, Epigenetics and DNA Methylation, Multiple Myeloma Research and Treatments, Histone Deacetylase Inhibitors Research, Protein Degradation and Inhibitors
Most-Cited Works
- → Mitochondria Are Required for Antigen-Specific T Cell Activation through Reactive Oxygen Species Signaling(2013)1,261 cited
- → EZH2 Is Required for Germinal Center Formation and Somatic EZH2 Mutations Promote Lymphoid Transformation(2013)832 cited
- → Alternative splicing: an emerging topic in molecular and clinical oncology(2007)270 cited
- → Histone Methyltransferase MMSET/NSD2 Alters EZH2 Binding and Reprograms the Myeloma Epigenome through Global and Focal Changes in H3K36 and H3K27 Methylation(2014)236 cited
- → The histone methyltransferase MMSET/WHSC1 activates TWIST1 to promote an epithelial–mesenchymal transition and invasive properties of prostate cancer(2012)159 cited
- → Point mutation E1099K in MMSET/NSD2 enhances its methyltranferase activity and leads to altered global chromatin methylation in lymphoid malignancies(2013)